ArticleArchives of medical science : AMS2013
Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults.
Article in Archives of medical science : AMS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01914640 (The Cross Sectional Study to Investigate the Waist Circumference Cut Off Points for the Prediction of Overweight and Obesity of the Turkish Adult Population), which is not on this map. Cited by 50 papers, 7 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Cross Sectional Study to Investigate the Waist Circumference Cut Off Points for the Prediction of Overweight and Obesity of the Turkish Adult Population
Who cites it
50 citing papers in PubMed, 7 syntheses or guidelines pooled it.
- Association between APOA5 polymorphisms and susceptibility to metabolic syndrome: a systematic review and meta-analysis.BMC genomics · 2024Pooled it
- Prevalence of metabolic syndrome in Brazilian adults in the last 10 years: a systematic review and meta-analysis.BMC public health · 2022Pooled it
- Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa-a systematic review and meta-analysis.Systematic reviews · 2019Pooled it
- Maternal Body Mass Index and Risk of Congenital Heart Defects in Infants: A Dose-Response Meta-Analysis.BioMed research international · 2019Pooled it
- The association between BMI and kidney cancer risk: An updated dose-response meta-analysis in accordance with PRISMA guideline.Medicine · 2018Pooled it
- Prevalence of metabolic syndrome in Mainland China: a meta-analysis of published studies.BMC public health · 2016Pooled it
- Prevalence of metabolic syndrome in Brazilian adults: a systematic review.BMC public health · 2013Pooled it
- Effects of Hormone Therapy on Oxidative Stress in Postmenopausal Women with Metabolic Syndrome.International journal of molecular sciences · 2016Trial
- Metabolic Syndrome in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease: A High Burden Driven by Cumulative Risk Factors.Journal of cardiovascular development and disease · 2026Article
- Uric acid-to-albumin ratio is associated with metabolic syndrome in a large adult cohort.Biomolecules & biomedicine · 2026Article
- Prevalence of Metabolic Syndrome and Its Components in a Population in the Algerian Sahara.Ethnicity & disease · 2025Article
- The association between gut microbiota composition and cardiometabolic parameters in healthy adults.BMC microbiology · 2025Article
- Patterns of type 2 diabetes risk factors using latent class analysis (LCA) model: a population-based study in the South of Iran, Kharameh cohort population.BMC public health · 2025Article
- Prevalence of Metabolic Syndrome in Iranian Adults Receiving Antiretroviral Treatment for HIV.Current HIV research · 2025Article
- The predictive power of conventional and novel obesity indices in identifying metabolic syndrome among the southern Iranian populations: findings from PERSIAN cohort study.Journal of health, population, and nutrition · 2024Article
- Review
- The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome.Life (Basel, Switzerland) · 2023Article
- Estimates and Forecasts on the Burden of Prediabetes and Diabetes in Adult and Elderly Population in Turkiye.European journal of epidemiology · 2023Article
- Association of NADFrontiers in endocrinology · 2023Article
- The prevalence of cardiometabolic multimorbidity and its associations with health outcomes among women in China.Frontiers in cardiovascular medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim of this study is to investigate the prevalence of metabolic syndrome (MS) and its components according to Adult Treatment Panel III (ATP III) and International Diabetes Federation (IDF) criteria and the risk factors affecting MS. Metabolic syndrome prevalence was evaluated according to certain quintet age groups, altitude, location and demographic features. MATERIAL AND
methodsThis study was a cross-sectional survey conducted in 24 provinces from the 7 regions of Turkey. A total of 4309 adults from 7 regions participated in the study (1947 males, 45.2%).
resultsThe mean age of participants was 47 ±14 years. Metabolic syndrome prevalence was found as 36.6% according to ATP III and 44.0% according to IDF. The MS rate was found to be higher in females compared to males in both groups (p < 0.01). According to both criteria, MS prevalence was found to be higher in subjects who lived in coastal regions when evaluated according to altitude and in subjects who lived in district centers when evaluated according to location. The MS risk is 1.62-fold higher in females compared to males. Metabolic syndrome risk increases as age increases and is highest in the 61-65 age group. Metabolic syndrome risk increases 2.75-fold in the overweight compared to normal weighing subjects and 7.80-fold in the obese.
conclusionsMetabolic syndrome prevalence was found to be high in Turkey according to both criteria. Metabolic syndrome prevalence increases as age and body mass index (BMI) increase. Age, female gender and obesity are independent risk factors for MS development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.